Assessment of Transnasal Humidified Rapid-insufflation Ventilatory Exchange (THRIVE) for Maternal Pre-oxygenation
NCT ID: NCT04814628
Last Updated: 2024-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1 participants
INTERVENTIONAL
2024-02-15
2024-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Flow Nasal Cannula to Prevent Deoxygenation During Induction of General Anesthesia in Cesarean Section
NCT04438798
Pre-oxygenation With High-flow Nasal Cannula in Caesarian Section Under General Anesthesia
NCT04711317
Application of High-flow Nasal Oxygen in Cesarean Section
NCT05921955
Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity
NCT00603603
Effect of Maternal and Neonatal Oxygenation
NCT01530971
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy volunteer subject
A single healthy volunteer subject will participate in the study as a model of a pregnant woman in the third trimester of pregnancy, with a functional respiratory capacity reduced by 20% thanks to elastic restraints performed under the control of functional respiratory explorations.
8 obstetric anesthesiologists will participate in the 4 scenarios;
scenario 1 : pre-oxygenation with a face mask held by the anaesthetist
the face mask is held by the anaesthetist (reference technique) to obtain effective pre-oxygenation for Oxygen Reserve Index (ORI) which has reached a plateau value for more than 10 seconds. All the usual supplies and medicines are available and in the same place as usual.
The sequence is as follows:
1. Patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Pre-oxygenation of the patient with the face mask held by the participating anaesthetist
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop
scenario 2: one anaesthetist in charge, face mask held by the patient for pre-oxygenation
one anaesthetist is in charge of the simulated patient (volunteer), face mask held by the volunteer for pre-oxygenation for ORI which has reached a plateau value for more than 10 seconds All the usual supplies and medicines are available and in the same place as usual.
The sequence is as follows:
1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Face mask held by the patient for pre-oxygenation
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop
scenario 3: one anaesthetist in charge, THRIVE used for pre-oxygenation
All the usual supplies and medicines are available and in the same place as usual.
The sequence is as follows:
1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. THRIVE for pre-oxygenation
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop
scenario 4: one anaesthetist and one nurse anaesthetist in charge, the face mask is held by the anaesthetist or the nurse anaesthetist
All the usual supplies and medicines are available and in the same place as usual.
The sequence is as follows:
1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Pre-oxygenation of the patient with the face mask held by the participating anaesthetist or nurse anaesthetist
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
scenario 1 : pre-oxygenation with a face mask held by the anaesthetist
the face mask is held by the anaesthetist (reference technique) to obtain effective pre-oxygenation for Oxygen Reserve Index (ORI) which has reached a plateau value for more than 10 seconds. All the usual supplies and medicines are available and in the same place as usual.
The sequence is as follows:
1. Patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Pre-oxygenation of the patient with the face mask held by the participating anaesthetist
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop
scenario 2: one anaesthetist in charge, face mask held by the patient for pre-oxygenation
one anaesthetist is in charge of the simulated patient (volunteer), face mask held by the volunteer for pre-oxygenation for ORI which has reached a plateau value for more than 10 seconds All the usual supplies and medicines are available and in the same place as usual.
The sequence is as follows:
1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Face mask held by the patient for pre-oxygenation
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop
scenario 3: one anaesthetist in charge, THRIVE used for pre-oxygenation
All the usual supplies and medicines are available and in the same place as usual.
The sequence is as follows:
1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. THRIVE for pre-oxygenation
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop
scenario 4: one anaesthetist and one nurse anaesthetist in charge, the face mask is held by the anaesthetist or the nurse anaesthetist
All the usual supplies and medicines are available and in the same place as usual.
The sequence is as follows:
1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Pre-oxygenation of the patient with the face mask held by the participating anaesthetist or nurse anaesthetist
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* female
* affiliated to a social security scheme or beneficiary of such a scheme
* having voluntarily and informedly agreed to participate in the study.
* non-smoker
* free from pulmonary, cardiac and neurological pathologies
* have a normal functional respiratory test at baseline.
Exclusion Criteria
* non-French speaking volunteer
* obesity defined by a body mass index greater than 30 kilogram/meter² (kg/m²)
* current pregnancy
* Volunteer in period of exclusion from further research
* Person under guardianship, curatorship or any other administrative or judicial measure of deprivation of rights and liberty
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Femme Mère Enfant
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A00047-34
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL20_1116
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.